Cite
HARVARD Citation
Morgan, R. et al. (2018). An Outpatient, Dose-Intense, Intravenous Cisplatin and Oral Etoposide Regimen for the Treatment of Advanced, Platinum-Resistant Ovarian Cancer. International journal of gynecological cancer. 28 (3), pp. 448-452. [Online].